GNLX vs ILMN · rev $8.0K vs rev $2.25B
Genelux Corporation Common Stock (GNLX) versus Illumina Inc (ILMN) — a side-by-side from cached financials, not a winner call.
Genelux Corporation Common Stock (GNLX) is a biotechnology company listed on US.
Illumina Inc (ILMN) is a diagnostics & research company listed on US. It is led by Jacob Thaysen Ph.D..
Latest reported GNLX revenue for 2025-12-31 was $8.0K. Net income was -$32.1M. Revenue was up 0.0% from 2024-12-31 to 2025-12-31. GNLX currently screens at market cap $130.6M.
Latest reported ILMN revenue for 2026-06-28 was $2.25B. Net income was $340.0M. ILMN currently screens at market cap $15.84B.
GNLX currently screens at market cap $130.6M. ILMN currently screens at market cap $15.84B.
Not investment advice. Open the GNLX and ILMN stock pages for the full models.
Not investment advice.